Grid eXplore Mapping Study
NCT: NCT07421076 · RECRUITING
Brief Summary
The purpose of the trial is to find out if the Grid X Mapping Catheter and EnSite X EP System with EnSite X Software v3.1.1, the devices that are being studied, are safe and effective in treating Chinese patients who have atrial fibrillation. Participants will receive a procedure called catheter mapping and ablation to treat their abnormal heart rhythms and are required to complete 4 follow-up visits at 7 days, 3 months, 6 months and 12 months after the procedure for checkups and tests.
Frequently Asked Questions
What is Grid eXplore Mapping Study?
Grid eXplore Mapping Study is a clinical trial registered under NCT07421076. Current status: RECRUITING.
What is the status of NCT07421076?
The current status of NCT07421076 (Grid eXplore Mapping Study) is: RECRUITING.
When did Grid eXplore Mapping Study start?
Grid eXplore Mapping Study started on 2026-04-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.